UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel...
Q1 2026
May 6, 2026
FY 2025
Mar 2, 2026
Q4 2025
Q3 2025
Nov 6, 2025
Q2 2025
Aug 7, 2025
